Table 4.

MMTT responses during the first 30 and 180 min postingestion

	MMTT control subjects (n = 10)	PS-CF (n = 8)	PI-CF (n = 11)#	Overall P value
				Control subjects vs. PI-CF	Control subjects vs. PS-CF	PS-CF vs. PI-CF
30 min
AUCglu (mg ⋅ min/dL)	540 (276–729)	447 (272–521)	462 (268–509)	0.60
AUCISR (pmol/L)	3,041 (1,459–4,721)	2,857 (1,950–4,201)	1,033 (200–1,677)	0.03*	0.03	0.02*
					0.80*
AUCISR/AUCglu (mU ⋅ min/mg)	0.09 (0.07–0.12)	0.16 (0.10–0.17)	0.05 (0.03–0.05)	0.007*	0.004	0.007*
					0.12*
AUCGLP-1 (pmol ⋅ min/L)	32 (21–81)	91 (52–121)	16 (10–71)	0.32*	0.04	0.02*
					0.05*
AUCGIP (pg ⋅ min/mL)	1,367 (734–1,838)	1,900 (1,048–2,354)	747 (355–1,195)	0.11*	0.04	0.02*
					0.34*
180 min
AUCglu (mg ⋅ min/dL)	506 (−145 to 2,958)	3,501 (2,707–5,123)	5,075 (2,836–7,989)	0.004*	0.007	0.46*
					0.02*
AUCISR (pmol/L)	25,917 (23,659–28,693)	53,375 (47,607–58,495)	26,156 (23,176–49,651)	0.60*	0.006	0.08*
					0.0004*
AUCISR/AUCglu (mU ⋅ min/mg)	0.13 (−0.93 to 0.19)	0.26 (0.15–0.35)	0.13 (0.08–0.16)	0.13
AUCGLP-1 (pmol ⋅ min/L)	395 (278–589)	577 (230–738)	216 (103–494)	0.27
AUCGIP (pg ⋅ min/mL)	34,702 (28,526–40,934)	30,586 (23,471–45,227)	18,721 (11,502–28,675)	0.006*	0.01	0.03*
					0.42*

Data are medians and IQRs. Glu, glucose.

*Between-group comparisons performed when overall P value was significant at P ≤ 0.05;

#n = 9 for AUC_ISR and AUC_ISR/AUC_glu.